Melissa M Farmer1, Danielle E Rose, Deborah Riopelle, Andy B Lanto, Elizabeth M Yano. 1. VA Health Services Research and Development Center of Excellence, Center for the Study of Healthcare Provider Behavior, VA Greater Los Angeles Healthcare System, Los Angeles, California 91343, USA. Melissa.Farmer@va.gov
Abstract
OBJECTIVES: Veterans experience a particularly heavy burden with smoking rates higher than the general population, and the smoking prevalence for women Veterans has increased in recent years. We examined differences in smoking prevalence and treatment by gender for Veterans receiving at least some of their care at a VA facility, and examined the degree to which organizational factors may be associated with reductions in gender disparities in smoking cessation treatment. METHODS: We merged national organizational-level data focused on primary care (sites = 225) and women's health (sites = 195) with patient-level survey data (n = 15,033 smokers). Organizational measures focused on smoking cessation-specific structure and processes in primary care and women's health. Primary outcomes were patient-reported receipt of smoking cessation treatments-advised to quit, medication recommendation, and other treatment recommendation. We used multi-level, random-intercept logistic regression. RESULTS: In 2007, 29% of women and 23% of men were smokers. Overall, 83% of smokers reported they had been advised to quit, 62% recommended medications, and 60% recommended other treatments. Women were more likely to report being advised to quit (odds ratio, 1.33; 95% confidence interval, 1.07-1.64) but equally likely as men to have medications or other treatment recommended. Organizational factors did not eliminate the gender differences in being advised to quit. CONCLUSION: Despite having equivalent or higher smoking cessation treatment rates, women Veterans were more likely to smoke than men. With the rapid growth of women entering VA care, the need for effective gender-focused and gender-sensitive smoking cessation care arrangements is critical for the future health of women who have served. Published by Elsevier Inc.
OBJECTIVES: Veterans experience a particularly heavy burden with smoking rates higher than the general population, and the smoking prevalence for women Veterans has increased in recent years. We examined differences in smoking prevalence and treatment by gender for Veterans receiving at least some of their care at a VA facility, and examined the degree to which organizational factors may be associated with reductions in gender disparities in smoking cessation treatment. METHODS: We merged national organizational-level data focused on primary care (sites = 225) and women's health (sites = 195) with patient-level survey data (n = 15,033 smokers). Organizational measures focused on smoking cessation-specific structure and processes in primary care and women's health. Primary outcomes were patient-reported receipt of smoking cessation treatments-advised to quit, medication recommendation, and other treatment recommendation. We used multi-level, random-intercept logistic regression. RESULTS: In 2007, 29% of women and 23% of men were smokers. Overall, 83% of smokers reported they had been advised to quit, 62% recommended medications, and 60% recommended other treatments. Women were more likely to report being advised to quit (odds ratio, 1.33; 95% confidence interval, 1.07-1.64) but equally likely as men to have medications or other treatment recommended. Organizational factors did not eliminate the gender differences in being advised to quit. CONCLUSION: Despite having equivalent or higher smoking cessation treatment rates, women Veterans were more likely to smoke than men. With the rapid growth of women entering VA care, the need for effective gender-focused and gender-sensitive smoking cessation care arrangements is critical for the future health of women who have served. Published by Elsevier Inc.
Authors: Ana M Progovac; Yue-Fang Chang; Chung-Chou H Chang; Karen A Matthews; Julie M Donohue; Michael F Scheier; Elizabeth B Habermann; Lewis H Kuller; Joseph S Goveas; Benjamin P Chapman; Paul R Duberstein; Catherine R Messina; Kathryn E Weaver; Nazmus Saquib; Robert B Wallace; Robert C Kaplan; Darren Calhoun; J Carson Smith; Hilary A Tindle Journal: Ann Behav Med Date: 2017-08
Authors: Sarah M Wilson; Alyssa M Medenblik; Julia M Neal; Jennifer L Strauss; J Murray McNiel; Warren E Christian; Jean C Beckham; Patrick S Calhoun Journal: Qual Health Res Date: 2019-07-16
Authors: Yasmin S Cypel; Kim Hamlett-Berry; Shannon K Barth; Dana E Christofferson; Victoria J Davey; Stephanie Eber; Aaron I Schneiderman; Robert M Bossarte Journal: Public Health Rep Date: 2016-09-16 Impact factor: 2.792
Authors: Kelly M Harrington; Xuan-Mai T Nguyen; Rebecca J Song; Keri Hannagan; Rachel Quaden; David R Gagnon; Kelly Cho; Jennifer E Deen; Sumitra Muralidhar; Timothy J O'Leary; John Michael Gaziano; Stacey B Whitbourne Journal: Womens Health Issues Date: 2019-06-25
Authors: Nikki R Wooten; Beth A Mohr; Lena M Lundgren; Rachel Sayko Adams; Elizabeth L Merrick; Thomas V Williams; Mary Jo Larson Journal: J Subst Abuse Treat Date: 2013-05-31
Authors: Andrea Z LaCroix; Eileen Rillamas-Sun; Nancy F Woods; Julie Weitlauf; Oleg Zaslavsky; Regina Shih; Michael J LaMonte; Chloe Bird; Elizabeth M Yano; Meryl LeBoff; Donna Washington; Gayle Reiber Journal: Gerontologist Date: 2016-02
Authors: Isabel Martinez Leal; Matthew Taing; Virmarie Correa-Fernández; Ezemenari M Obasi; Bryce Kyburz; Kathy Le; Litty Koshy; Tzuan A Chen; Teresa Williams; Kathleen Casey; Daniel P O'Connor; Lorraine R Reitzel Journal: Int J Environ Res Public Health Date: 2021-05-27 Impact factor: 4.614